Alkermes Plc
(NASDAQ) ALKS
Alkermes Plc Financials at a Glance
Market Cap
$7.38B
Revenue (TTM)
$1.56B
Net Income (TTM)
$152.72M
EPS (TTM)
$0.90
P/E Ratio
49.23
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$44.26
Volume
1,523,226.72
Open
$45.10
Price
$44.26
Volume
1,523,226.72
Open
$45.10
Previous Close
$44.28
Daily Range
$44.22 - $45.71
52-Week Range
$25.17 - $45.76
Estimated Earnings Date
Jul 28, 2026
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$44.26
Volume
1,523,226.72
Open
$45.10
Previous Close
$44.28
Daily Range
$44.22 - $45.71
52-Week Range
$25.17 - $45.76
Estimated Earnings Date
Jul 28, 2026
ALKS News
Best Biotech ETFs to Buy in 2026
ALKS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alkermes Plc
Industry
Biotechnology
Sector
Health CareEmployees
2,050
CEO
Richard F. Pops
Website
www.alkermes.comHeadquarters
Dublin, 4, US
ALKS Financials
Key Financial Metrics (TTM)
Gross Margin
87%
Operating Margin
12%
Net Income Margin
10%
Return on Equity
9%
Return on Capital
5%
Return on Assets
4%
Earnings Yield
2.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.38B
Shares Outstanding
166.68M
Volume
1.52M
Avg. Volume
2.33M
Financials (TTM)
Gross Profit
$1.28B
Operating Income
$253.96M
EBITDA
$330.89M
Operating Cash Flow
$520.75M
Capital Expenditure
-$40.42M
Free Cash Flow
$480.33M
Cash & ST Invst.
$1.32B
Total Debt
$70.00M
Alkermes Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$392.91M
+28.2%
Gross Profit
$331.33M
+28.8%
Gross Margin
84.33%
N/A
Market Cap
$7.38B
N/A
Market Cap/Employee
$4.10M
N/A
Employees
1,800
N/A
Net Income
-$66.48M
-395.9%
EBITDA
-$21.61M
-165.6%
Quarterly Fundamentals
Total Cash
$511.86M
-42.1%
Total Debt
$1.58B
+2034.4%
Accounts Receivable
$407.63M
+26.7%
Inventory
$336.70M
+83.6%
Long Term Debt
$1.55B
+2182.2%
Short Term Debt
$34.08M
+441.7%
Return on Assets
3.59%
N/A
Return on Invested Capital
5.24%
N/A
Free Cash Flow
-$169.83M
-291.5%
Operating Cash Flow
-$165.74M
-267.7%